Orthogonal Peptides
Pharmaceutical Manufacturing • 
London, England, United Kingdom • 1-10 Employees
Company overview
| Headquarters | London, South Kensington SW7 2AZ, GB |
| Website | |
| NAICS | 3254 |
| Founded | 2025 |
| Employees | 1-10 |
Key Contact at Orthogonal Peptides
Othman Al Musaimi
Chief Technology Officer and Co-Founder
About Orthogonal Peptides
Orthogonal Peptides is a biotech technology platform enabling the creation of novel, complex peptide structures through next-generation synthesis and purification. Our platform integrates proprietary synthesis methods with advanced chromatography, making peptide innovation faster, greener, and scalable. This unlocks access to cyclic peptides, ligand-modified constructs, and highly functionalized architectures that traditional technologies cannot reliably produce. By addressing the twin bottlenecks of synthesis and purification, Orthogonal Peptides accelerates the development of next-generation therapeutics, while reducing costs and environmental impact. Our mission is to expand the boundaries of peptide science and accelerate the translation of life-changing medicines from research to patients. Specialties: Complex Peptide Structures • Synthesis Technology • Chromatography • Biotech Platforms • Drug Discovery • Green Chemistry • Therapeutics Development
Orthogonal Peptides revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Orthogonal Peptides has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Orthogonal Peptides has never raised funding before.
Canada
United States
AustraliaFrequently asked questions
4.8
40,000 users
